You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

HALOPERIDOL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for haloperidol and what is the scope of patent protection?

Haloperidol is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Actavis Group, Aiping Pharm Inc, Chartwell Rx, Duramed Pharms Barr, Innogenix, Lederle, MSN, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sciegen Pharms Inc, SCS, Strides Pharma, Upsher Smith Labs, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Mankind Pharma, Meitheal, Mylan Labs Ltd, Sandoz, Somerset Theraps Llc, Teva Pharms Usa, Zydus Pharms, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Rubicon, Teva, Teva Pharms, Abraxis Pharm, Baxter Hlthcare Corp, Epic Pharma Llc, Fosun Pharma, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol. Twenty-one suppliers are listed for this compound.

Drug Prices for HALOPERIDOL

See drug prices for HALOPERIDOL

Drug Sales Revenue Trends for HALOPERIDOL

See drug sales revenues for HALOPERIDOL

Recent Clinical Trials for HALOPERIDOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Christian HassagerPhase 3
Qilu Pharmaceutical Co., Ltd.Phase 3
Cancer Prevention Research Institute of TexasPhase 2/Phase 3

See all HALOPERIDOL clinical trials

Pharmacology for HALOPERIDOL
Medical Subject Heading (MeSH) Categories for HALOPERIDOL

US Patents and Regulatory Information for HALOPERIDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs HALOPERIDOL haloperidol TABLET;ORAL 211061-001 Jan 8, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs HALOPERIDOL haloperidol TABLET;ORAL 071376-001 Jun 3, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 205241-001 May 12, 2017 AO RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 074893-001 Dec 19, 1997 AO RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Group HALOPERIDOL haloperidol TABLET;ORAL 200854-005 Jul 1, 2022 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aiping Pharm Inc HALOPERIDOL haloperidol TABLET;ORAL 071133-001 May 12, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for HALOPERIDOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-003 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-006 Feb 2, 1982 ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-004 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-005 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.